6df3 Citations

Crystal Structure of the Labile Complex of IL-24 with the Extracellular Domains of IL-22R1 and IL-20R2.

J Immunol 201 2082-2093 (2018)
Cited: 7 times
EuropePMC logo PMID: 30111632

Abstract

Crystal structure of the ternary complex of human IL-24 with two receptors, IL-22R1 and IL-20R2, has been determined at 2.15 Å resolution. A crystallizable complex was created by a novel approach involving fusing the ligand with a flexible linker to the presumed low-affinity receptor, and coexpression of this construct in Drosophila S2 cells together with the presumed high-affinity receptor. This approach, which may be generally applicable to other multiprotein complexes with low-affinity components, was necessitated by the instability of IL-24 expressed by itself in either bacteria or insect cells. Although IL-24 expressed in Escherichia coli was unstable and precipitated almost immediately upon its refolding and purification, a small fraction of IL-24 remaining in the folded state was shown to be active in a cell-based assay. In the crystal structure presented here, we found that two cysteine residues in IL-24 do not form a predicted disulfide bond. Lack of structural restraint by disulfides, present in other related cytokines, is most likely reason for the low stability of IL-24. Although the contact area between IL-24 and IL-22R1 is larger than between the cytokine and IL-20R2, calculations show the latter interaction to be slightly more stable, suggesting that the shared receptor (IL-20R2) might be the higher-affinity receptor.

Articles - 6df3 mentioned but not cited (5)

  1. Chemical composition, antioxidant, anti-inflammatory, and cytotoxic activities of Opuntia stricta cladodes. Izuegbuna O, Otunola G, Bradley G. PLoS One 14 e0209682 (2019)
  2. In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells. Ghavimi R, Mohammadi E, Akbari V, Shafiee F, Jahanian-Najafabadi A. Res Pharm Sci 15 200-208 (2020)
  3. Crystal Structure of the Labile Complex of IL-24 with the Extracellular Domains of IL-22R1 and IL-20R2. Lubkowski J, Sonmez C, Smirnov SV, Anishkin A, Kotenko SV, Wlodawer A. J Immunol 201 2082-2093 (2018)
  4. In Silico Investigation of a Chimeric IL24-LK6 Fusion Protein as a Potent Candidate Against Breast Cancer. Muhammad Rehman H, Rehman HM, Naveed M, Khan MT, Shabbir MA, Aslam S, Bashir H. Bioinform Biol Insights 17 11779322231182560 (2023)
  5. Regulation of IL-24/IL-20R2 complex formation using photocaged tyrosines and UV light. Pham PN, Zahradník J, Kolářová L, Schneider B, Fuertes G. Front Mol Biosci 10 1214235 (2023)


Reviews citing this publication (1)

  1. Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein. Modi J, Roy A, Pradhan AK, Kumar A, Talukdar S, Bhoopathi P, Maji S, Mannangatti P, Sanchez De La Rosa D, Li J, Guo C, Subler MA, Windle JJ, Cavenee WK, Sarkar D, Wang XY, Das SK, Emdad L, Fisher PB. Int J Mol Sci 23 72 (2021)

Articles citing this publication (1)

  1. Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking. Pradhan AK, Bhoopathi P, Talukdar S, Das SK, Emdad L, Sarkar D, Ivanov AI, Fisher PB. Oncotarget 10 5103-5117 (2019)